🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

E' Pierluigi Toniutto il nuovo coordinatore della Commissione Trapianti AISF. Quali sono gli obiettivi e le progettualità di tale gruppo? buff.ly/44hHsQg

➡️ 342 patients evaluated for LT in Rome-Gemelli-Center ➡️ 307 patients evaluated for LT IN Turin Center ❌ unsatisfying performance of CAR-OLT score in predicting MACE after LT ❌ limited applicability of CAR-OLT score in cohorts different from the original one

HCC treatment perspective changes this July! Look here 📖 sciencedirect.com/science/articl… .EASLnews .AISF - Associazione Italiana Studio Fegato .AASLD massimo iavarone Giuseppe Cabibbo quirino lai andrea casadei gardini Alessandro Vitale David James Pinato 🇺🇦

Honored to be in this group of people who aspire to change the world 🌍...there are so many others besides us, who knows if we will succeed! 🥸 We have the passion 🔥 the tools 👩🏼‍⚕️ and the will 💫 to do it! FORTUNE #liver #cancer #research fortuneita.com/40under40-2023/

I am deeply honored to shine as UEG Rising ⭐️ 2024! Another milestone achieved through so much determination in #gut #microbiota and #liver disease research and the support of colleagues/friends! my_UEG EASL Education #EHMSG

L’#epatocarcinoma ha un’incidenza maggiore nei pazienti over 75. Questo comporta un approccio terapeutico molto più ponderato per il quale bisogna valutare con molta attenzione lo stato fisico e mentale del paziente. #HCC Ce ne parla Francesca Romana Ponziani. 🎙️bit.ly/3SDRit1

Introducing: myUEG Community Daily 🤩 We’re here for you year-round! It’s our pleasure to provide this newly redesigned overview highlighting everything on the agenda. 💭😌🗓️ All things multidisciplinary and GI-related are coming in hot this winter ❄️ bit.ly/3R0Sjco

Future Modulation of Gut #Microbiota: From Eubiotics to #FMT, Engineered Bacteria, and Phage Therapy. mdpi.com/2079-6382/12/5… MDPI Andrea Severino, William Fusco, Ben Mullish, Antonio Gasbarrini, Giovanni Cammarota,Francesca Romana Ponziani, Gianluca Ianiro and coll

WHO LASTS IT WINS... We are really proud that our concept of "multiparametric therapeutic hierarchy" is now cited and taken as an example to follow in the new British guidelines on the management of hepatocellular carcinoma published in the prestigious journal Gut…

What Is the Best Local Therapy for HCC? "The article in this issue of JAMA Surgery by Vitale et al is a SUPERB multicenter collected series composed of data from 2 large Italian registries collected between 2008 and 2020.” Yuman Fong; Jonathan Kessler jamanetwork.com/journals/jamas…

❓Persistent and unexplained elevated #GGT❓ 🔎Discover what predicts #PSVD in our 🆕 paper🔥 on JHEP Reports 🔥 Alessio Aghemo Francesca Romana Ponziani Luca Valenti @CristianaBianco

🌟 Watch Rising Stars shine at UEG Week! 🌟 Don't miss this captivating session by our Rising Star Francesca Romana Ponziani at #UEGWeek 2024: 'Gut microbiota and hepatocellular carcinoma: From pathogenesis to modulation of treatment efficacy.' 🔗 bit.ly/3LW6a1y #myUEGcommunity

Francesca Romana Ponziani Olga Nyssen Mette Julsgaard @hanneshagstrom Universitätsmedizin Göttingen (UMG)

Our paper selected as Editor’s choice! 📖 a deep insight into 🐛 Akkermansia muciniphila’s role in human diseases 💉 check it out! 🔎 mdpi.com/2072-6643/15/8…

👉A post-hoc analysis from the IMbrave150 🔥 ⁠Is it time to redesign the HCC trial design? 💥Clinical Hepatic decompensation is the major driver of death in patients with HCC doi.org/10.1158/1078-0… David James Pinato 🇺🇦 Maria Reig Amit G Singal Arndt Vogel massimo iavarone Ciro Celsa Clinical Cancer Research

THE END OF THE STAGE HIERARCHY HCC ERA ... ... towards the MTH approach for patients with HCC ... [272] Vitale A, et al. Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept. Lancet Oncol 2023;24(7):e312–e322.

Can we identify HCC patients at risk of liver decompensation during 💉Atezolizumab-Bevacizumab❓And what should we do if decompensation occurs during treatment🤔❓Is discontinuation always the only option 🙂‍↔️❓ Find the answers in our new paper❗️📄 sciencedirect.com/science/articl…

Liver decompensation is much more than just an adverse event—it should be considered a true outcome!😱 In our paper, we used for the first time Time to Decompensation (TTD) as an outcome in HCC patients receiving Atezolizumab-Bevacizumab. 👍🏻 find it out ➡️ sciencedirect.com/science/articl…

AISF 2025: challenging issues in #liver #transplant drugs #abuse #ageing and social #frailty on the stage ⁦AISF - Associazione Italiana Studio Fegato⁩ ⁦EASLnews⁩ ⁦EASL Education⁩

4ever #young # 😂🫠 AISF2025 ⁦AISF - Associazione Italiana Studio Fegato⁩ ⁦Salvatore Petta⁩ ⁦Alessio Aghemo⁩